As contract negotiations continue for flight attendants at Alaska Airlines and its wholly owned subsidiary Horizon Air, the mainline group is nearing a second tentative agreement (TA). At Alaska, language is being finalized on an Agreement in Concept (AIC) before it can be sent to membership as a...

TA Associates (“TA” or the “Firm”), a leading global private equity firm, announced today that its holding company, Project Neptune BidCo GmbH, successfully completed its tender offer (the “Offer”) to acquire all outstanding ordinary shares and stock acquisition rights of Nexus AG (“Nexus”),

Gamtaan kunis kanneen baha jidduugalaatti ijoo ta'an keessaa tokko. Kanneen garee kana hundeessan keessaa tokko kan ta'an Qaasiil Suleeyimaanii Baagdaad keessatti erga ajjeeffamanii waggaa shan ta'era.

The implementation of the hostage deal helping Likud party gain strength. Naftali Bennett's possible return to politics continues to change the balance of power.

It started with an attempt to help visually impaired tennis fans. The cartoon feeds of the world’s best tennis players are a sign of a greater shift in consumption.

An ex-Talawanda School District aide arrested last month for endangering a child has waived her right to a speedy trial and will not face a judge again until March, according to court records. Heather Keller,

Tennis Australia is advising players against competing in Russia amid reports Davis Cup star Thanasi Kokkinakis featured in a lucrative exhibition event in

Whole wheat bread is generally healthier than white bread because it contains more nutrients and fiber. However, the right choice depends on your goals and needs.

Sirna kakuu galuu Pirezidaant Tiraamp Wiixata darbe gaggeeffame irratti paastaroonni Afrikaa lama argamanii turan.

Analysts have fine-tuned CapitaLand Malaysia Trust’s (CLMT) earnings forecasts for the upcoming financial years, following the group’s strong net profit for the year ended Dec 31, 2024 (FY24).

Gadang Holdings Bhd’s property division is expected to remain a key contributor, driven by attractive sales incentives and an aggressive pricing strategy.

SAN DIEGO, CA / ACCESS Newswire / January 23, 2025 / Dermata Therapeutics, Inc. (NASDAQ:DRMA)(NASDAQ:DRMAW) ("Dermata," or the "Company"), a late-stage biotechnology company focused on the treatment of medical and aesthetic skin diseases and conditions,